金陵药业
(000919)
| 流通市值：39.36亿 | | | 总市值：39.37亿 |
| 流通股本：6.22亿 | | | 总股本：6.22亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 768,671,414.38 | 3,197,324,288.02 | 2,380,142,974.77 | 1,601,071,008.21 |
| 营业总成本 | 747,885,190.74 | 3,159,275,152.03 | 2,318,855,766.79 | 1,565,898,002.66 |
| 其他经营收益 | | | | |
| 营业利润 | 35,069,187.03 | 69,238,916.33 | 89,602,810.98 | 60,490,316.9 |
| 利润总额 | 34,920,563.36 | 65,191,315.78 | 89,711,144.03 | 60,989,017.77 |
| 净利润 | 29,642,644.92 | 51,292,285.96 | 74,818,279.63 | 50,416,925.32 |
| 每股收益 | | | | |
| 其他综合收益 | 0 | -75,520.53 | -75,520.53 | 0 |
| 综合收益总额 | 29,642,644.92 | 51,216,765.43 | 74,742,759.1 | 50,416,925.32 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 3,751,786,749.57 | 3,797,747,980.29 | 3,543,965,287.99 | 3,638,929,325.31 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,264,482,036.9 | 2,209,064,980.01 | 2,480,031,659.52 | 2,415,617,701.93 |
| 资产总计 | 6,016,268,786.47 | 6,006,812,960.3 | 6,023,996,947.51 | 6,054,547,027.24 |
| 流动负债: | | | | |
| 流动负债合计 | 955,286,952.32 | 975,949,164.33 | 960,668,321.51 | 1,015,211,546.34 |
| 非流动负债: | | | | |
| 非流动负债合计 | 209,165,185.98 | 208,770,520.28 | 216,225,910.96 | 216,323,138.15 |
| 负债合计 | 1,164,452,138.3 | 1,184,719,684.61 | 1,176,894,232.47 | 1,231,534,684.49 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,805,778,572.93 | 3,777,722,966.83 | 3,792,363,193.16 | 3,772,432,638.51 |
| 股东权益合计 | 4,851,816,648.17 | 4,822,093,275.69 | 4,847,102,715.04 | 4,823,012,342.75 |
| 负债和股东权益合计 | 6,016,268,786.47 | 6,006,812,960.3 | 6,023,996,947.51 | 6,054,547,027.24 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 763,187,319.12 | 3,299,466,083.25 | 2,455,304,723.81 | 1,633,518,736.5 |
| 经营活动现金流出小计 | 764,235,078.81 | 3,125,256,834.12 | 2,366,012,446.22 | 1,617,674,437.64 |
| 经营活动产生的现金流量净额 | -1,047,759.69 | 174,209,249.13 | 89,292,277.59 | 15,844,298.86 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 135,852,606.69 | 1,183,661,079.43 | 981,304,075.51 | 716,972,649.44 |
| 投资活动现金流出小计 | 440,917,674.45 | 1,493,067,056.59 | 1,565,094,086.64 | 1,294,535,097.47 |
| 投资活动产生的现金流量净额 | -305,065,067.76 | -309,405,977.16 | -583,790,011.13 | -577,562,448.03 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 0 | 0 | 0 | 0 |
| 筹资活动现金流出小计 | 1,558,501.4 | 85,076,073.18 | 82,469,941.34 | 7,522,456.21 |
| 筹资活动产生的现金流量净额 | -1,558,501.4 | -85,076,073.18 | -82,469,941.34 | -7,522,456.21 |
| 汇率变动对现金及现金等价物的影响 | -6,356.94 | 8,450.56 | 10,367.79 | 17,563.95 |
| 现金及现金等价物净增加额 | -307,677,685.79 | -220,264,350.65 | -576,957,307.09 | -569,223,041.43 |
| 期末现金及现金等价物余额 | 1,053,425,930.98 | 1,361,103,616.77 | 1,004,410,660.33 | 1,012,144,925.99 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -220,264,350.65 | - | -569,223,041.43 |